The EUROPA Trial: Can an ACE Inhibitor Reduce CV Events in Stable CAD Patients Across the Risk Spectrum? 1,2 …Even in patients ≤55 years of age

Learn more about the EUROPA trial inclusion criteria and patient demographics  Learn more about the EUROPA risk reduction results  Learn more about the EUROPA results in a broad range of stable CAD patients